Journal of Virology · 2020 · 14 citations · 50 references
PharmacyImmunologyInfectious DiseasesAntibody EngineeringMolecular VirologyMonoclonal AntibodiesAntibody CharacterizationAntibody DiscoveryAntibody FunctionAntibody-antigen RecognitionMonoclonal Antibody TherapyTherapeutic Monoclonal AntibodiesAntibodiesAntibody-mediated Viral NeutralizationAntiviral TherapeuticsConformational Epitope BindingHemagglutination Inhibition AssaysInfluenza TreatmentMonoclonal Antibody RecognitionNeutralizing Antibody Escape
Respiratory diseases caused by influenza viruses still pose a serious concern to global health, and neutralizing antibodies constitute a promising area of antiviral therapeutics. However, the potential application of antibodies is often hampered by the challenge in generating nonimmunogenic antibodies in large scale. In the present study, transchromosomic (Tc) cattle were used for the generation of nonimmunogenic monoclonal antibodies (MAbs), and characterization of such MAbs revealed one monoclonal antibody, 53C10, exhibiting a potent neutralization activity against H1N1 influenza viruses. Further characterization of the neutralization escape mutant generated using this MAb showed that three amino acid substitutions in the HA head domain contributed to the resistance. These findings emphasize the importance of Tc cattle in the production of nonimmunogenic MAbs and highlight the potential of MAb 53C10 in the therapeutic application against H1 influenza virus infection in humans.
50
WebLogo: A Sequence Logo Generator: Figure 1
Gavin E. Crooks, Gary C. Hon, John‐Marc Chandonia et al. · Genome Research · 2004 · 13K citations · Full text
Antibody neutralization and escape by HIV-1
Xiping Wei, Julie M. Decker, Shuyi Wang et al. · Nature · 2003 · 2.4K citations
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker, Michael Huber, Katie J. Doores et al. · Nature · 2011 · 1.5K citations